ArticleCancer research2014

CCR5 receptor antagonists block metastasis to bone of v-Src oncogene-transformed metastatic prostate cancer cell lines.

Daniela Sicoli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.